Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.3500 (-4.26%) ($1.3500 - $1.3500) on Mon. Dec. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.02% (three month average) | RSI | 34 | Latest Price | $1.3500(-4.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -4.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) TIP(14%) VIXM(10%) GLD(9%) UNG(9%) UUP(9%) | Factors Impacting ANPC price | ANPC will decline at least -3.01% in a week (0% probabilities). IFRA(-20%) XLP(-19%) SDY(-19%) SPLV(-17%) VYM(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.01% (StdDev 6.02%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-27.35(-2125.93%) | Resistance Level | $1.77 | 5 Day Moving Average | $1.55(-12.9%) | 10 Day Moving Average | $1.62(-16.67%) | 20 Day Moving Average | $1.77(-23.73%) | To recent high | -61.2% | To recent low | 0% | Market Cap | $12m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |